Sudden cardiac death due to arrhythmias, such as atrial fibrillation or ventricular
tachycardia, account for 15–20% of all deaths. Myocardial infarction increases the burden of …

Patients treated with cardiac stereotactic body radiation therapy (radioablation) for refractory
ventricular arrhythmias are patients with advanced structural heart disease and significant …

Background Catheter ablation improves ventricular tachycardia (VT) event-free (time to
event) survival in patients with antiarrhythmic drug (AAD)-refractory VT and previous …

Experimental design allows us to more accurately determine the causal relationship
between variables correlated over time as compared to observational design based on …

Recurrent ventricular tachycardia (VT) in patients with prior myocardial infarction is
associated with adverse quality of life and clinical outcomes, despite the presence of …

Background Continuous electrocardiographic (ECG) monitoring is used to identify
ventricular tachycardia (VT), but false alarms occur frequently. Objective The purpose of this …

Catheter ablation is an effective and safe treatment for ventricular tachycardia attributable to
structural heart disease, reducing the risk of recurrent arrhythmias and defibrillator shock …

Ventricular tachycardia is a potentially life-threatening arrhythmia associated with an overall
high morbi-mortality, particularly in patients with structural heart disease. Despite their …

Myotonic dystrophy is a hereditary disorder with systemic involvement. The Italian Neuro-
Cardiology Network (INCN-RNC) is a unique collaborative experience involving neurology …

Introduction and objectives Sodium-glucose cotransporter type 2 inhibitors (SGLT2i) have
been associated with improved prognosis in patients with heart failure, but their impact on …